In the preceding three months, 5 analysts have released ratings for G1 Therapeutics (NASDAQ:GTHX), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $10.8, along with a high estimate of $14.00 and a low estimate of $4.00. Surpassing the previous average price target of $9.50, the current average has increased by 13.68%.
Deciphering Analyst Ratings: An In-Depth Analysis
An in-depth analysis of recent...
Login or create a forever free account to read this news
Sign up/Log in